NO20091374L - Pyrrolotriazin kinase inhibitorer - Google Patents

Pyrrolotriazin kinase inhibitorer

Info

Publication number
NO20091374L
NO20091374L NO20091374A NO20091374A NO20091374L NO 20091374 L NO20091374 L NO 20091374L NO 20091374 A NO20091374 A NO 20091374A NO 20091374 A NO20091374 A NO 20091374A NO 20091374 L NO20091374 L NO 20091374L
Authority
NO
Norway
Prior art keywords
kinase inhibitors
formula
pyrrolotriazine kinase
pyrrolotriazine
compounds
Prior art date
Application number
NO20091374A
Other languages
English (en)
Norwegian (no)
Inventor
Ping Chen
Brian E Fink
Original Assignee
Bristol Myers Squibb Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Squibb Co filed Critical Bristol Myers Squibb Co
Publication of NO20091374L publication Critical patent/NO20091374L/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
NO20091374A 2006-11-03 2009-04-03 Pyrrolotriazin kinase inhibitorer NO20091374L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US86417506P 2006-11-03 2006-11-03
PCT/US2007/083436 WO2008057994A2 (en) 2006-11-03 2007-11-02 Pyrrolotriazine kinase inhibitors

Publications (1)

Publication Number Publication Date
NO20091374L true NO20091374L (no) 2009-07-21

Family

ID=39365255

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20091374A NO20091374L (no) 2006-11-03 2009-04-03 Pyrrolotriazin kinase inhibitorer

Country Status (6)

Country Link
US (1) US7982033B2 (enExample)
EP (1) EP2081936B1 (enExample)
JP (1) JP5180967B2 (enExample)
CN (1) CN101535312B (enExample)
NO (1) NO20091374L (enExample)
WO (1) WO2008057994A2 (enExample)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT2041138E (pt) 2006-07-07 2014-10-07 Bristol Myers Squibb Co Inibidores de pirrolotriazina quinase
US8268998B2 (en) * 2006-11-03 2012-09-18 Bristol-Myers Squibb Company Pyrrolotriazine kinase inhibitors
CN102105150B (zh) 2008-05-21 2014-03-12 阿里亚德医药股份有限公司 用作激酶抑制剂的磷衍生物
JP5592890B2 (ja) * 2008-10-08 2014-09-17 ブリストル−マイヤーズ スクイブ カンパニー ピロロトリアジンキナーゼ阻害剤
TW201035100A (en) 2008-12-19 2010-10-01 Cephalon Inc Pyrrolotriazines as ALK and JAK2 inhibitors
JP5093527B2 (ja) * 2010-02-10 2012-12-12 日本電気株式会社 複合光導波路、波長可変フィルタ、波長可変レーザ、および光集積回路
CA2809331C (en) * 2010-08-27 2018-09-25 Merck Patent Gmbh Triazolopyrazine derivatives
CN103848833B (zh) * 2012-11-28 2016-08-31 上海希迈医药科技有限公司 吡咯并三嗪类衍生物、其制备方法及其在医药上的应用
RU2650512C2 (ru) 2013-09-18 2018-04-16 Бейджин Ханми Фармасьютикал Ко., Лтд. Соединение, ингибирующее активности киназ ВТК и/или JAK3
CN104974163B (zh) * 2014-04-14 2017-11-07 广东东阳光药业有限公司 取代的杂芳基化合物及其组合物和用途
FR3025717A1 (fr) * 2014-09-16 2016-03-18 Univ Lille Sciences Tech Utilisation conjointe d'un inhibiteur de trka et d'un inhibiteur de epha2 pour une utilisation dans le traitement de cancers
WO2016190847A1 (en) * 2015-05-26 2016-12-01 Calitor Sciences, Llc Substituted heteroaryl compounds and methods of use
WO2017004134A1 (en) * 2015-06-29 2017-01-05 Nimbus Iris, Inc. Irak inhibitors and uses thereof

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000071129A1 (en) 1999-05-21 2000-11-30 Bristol-Myers Squibb Company Pyrrolotriazine inhibitors of kinases
US6982265B1 (en) 1999-05-21 2006-01-03 Bristol Myers Squibb Company Pyrrolotriazine inhibitors of kinases
US6670357B2 (en) 2000-11-17 2003-12-30 Bristol-Myers Squibb Company Methods of treating p38 kinase-associated conditions and pyrrolotriazine compounds useful as kinase inhibitors
EE200300227A (et) 2000-11-17 2003-10-15 Bristol-Myers Squibb Company P38 kinaasiga seotud haigusseisundite ravimeetodid ja kinaasi inhibiitoritena kasulikud pürrolotriasiiniühendid
BR0309669A (pt) 2002-04-23 2005-03-01 Bristol Myers Squibb Co Compostos de anilina de pirrolo-triazina úteis como inibidores de cinase
AU2003265349A1 (en) 2002-08-02 2004-02-23 Bristol-Myers Squibb Company Pyrrolotriazine kinase inhibitors
CA2425123C (en) * 2003-01-16 2010-09-21 Decoma International Inc. Lightweight composite tailgate
WO2008021859A1 (en) 2006-08-09 2008-02-21 Bristol-Myers Squibb Company Pyrrolotriazine kinase inhibitors
US7531539B2 (en) 2006-08-09 2009-05-12 Bristol-Myers Squibb Company Pyrrolotriazine kinase inhibitors
WO2008131050A1 (en) 2007-04-18 2008-10-30 Bristol-Myers Squibb Company Pyrrolotriazine kinase inhibitors

Also Published As

Publication number Publication date
US20100081662A1 (en) 2010-04-01
CN101535312A (zh) 2009-09-16
WO2008057994A2 (en) 2008-05-15
JP5180967B2 (ja) 2013-04-10
JP2010509348A (ja) 2010-03-25
US7982033B2 (en) 2011-07-19
CN101535312B (zh) 2013-04-24
WO2008057994A3 (en) 2008-09-12
EP2081936B1 (en) 2014-04-02
EP2081936A2 (en) 2009-07-29

Similar Documents

Publication Publication Date Title
NO20091374L (no) Pyrrolotriazin kinase inhibitorer
NO20082023L (no) Pyrrolotriazin kinaseinhibitorer
NO20090025L (no) Pyrrolotriazinkinaseinhibitorer
MX2007001127A (es) Moduladores de pirrolo-piridina cinasa.
NO20062188L (no) Pyrazolderivater som inhibitorer av reseptor tyrosin kinaser
EA201100580A1 (ru) Имидазопиридазинкарбонитрилы, используемые в качестве ингибиторов киназы
WO2008060907A3 (en) Pyrrolo-pyridine kinase inhibitors
NO20081454L (no) Met-kinaseinhibitorer
ATE430747T1 (de) 2-pyrimidinyl-pyrazolopyridin-erbb- kinaseinhibitoren
ATE469151T1 (de) Pyrrolopyridinderivate als proteinkinaseinhibitoren
NO20081893L (no) 4-(3-aminopyrazol)pyrimidinderivater til anvendelse som tyrosin-kinaseinhibitorer i behandling av kreft
NO20074275L (no) 2- (4-okso-4H-kinazolin-3-yl) acetamider og deres anvendelse som Vasopressin-V3-antagonister
DE602008005771D1 (de) Disubstituierte alkyl-8-azabicycloä3.2.1üoktan-verbindungen als mu-opioid-rezeptorantagonisten
MX2009006170A (es) Compuestos y composiciones como inhibidores de cinasa.
ATE527253T1 (de) Pyrimidin-substituierte benzimidazolderivate als proteinkinasehemmer
ECSP077994A (es) Aminopirimidinas como moduladores de cinasa
NO20082285L (no) 3-aminosyklopentankarboksamider som modulatorer av kjemokinreseptorer
ECSP077997A (es) Moduladores de alquilquinolina y alquilquinazolina cinasa
NO20092035L (no) Tiazolylforbindelser anvendbare som kinaseinhibitorer
NI200700316A (es) Aminopirimidinas como moduladores de la cinasa
EA200700365A1 (ru) Производные индол-2-карбоксамидина как антагонисты nmda рецептора
NO20080553L (no) Azinyl-3-sulfonylindazolderivater som 5-hydroksytrypyamin-6 ligander
NO20080937L (no) Substituerte-3-sulfonylindazolderivater som 5-hydroksytryptamin-6-ligander
MY139016A (en) PYRAZOLOPYRIDINE DERIVATIVES AS INHIBITORS OF ß-ADRENERGIC RECEPTOR KINASE 1
NO20080160L (no) Mellomprodukter nyttige i syntesene av alkylkinolin og alkylkinazolin kinasemodulatorer og beslektede fremgangsmater for synteser

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application